BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21604987)

  • 41. Challenges in immunisation against bacterial infection in children.
    Trück J; Pollard AJ
    Early Hum Dev; 2010 Nov; 86(11):695-701. PubMed ID: 20851537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.
    Pollard AJ; Perrett KP; Beverley PC
    Nat Rev Immunol; 2009 Mar; 9(3):213-20. PubMed ID: 19214194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy.
    Blanchard-Rohner G; Pollard AJ
    Expert Rev Vaccines; 2011 May; 10(5):673-84. PubMed ID: 21604987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conjugate vaccines--a breakthrough in vaccine development.
    Mäkelä PH
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
    Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
    Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Conjugated vaccines].
    Swennen B; Sternon J
    Rev Med Brux; 2002 Jun; 23(3):165-74. PubMed ID: 12143156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunological principles of polysaccharide-protein conjugate vaccination].
    Meyer M; Gahr M
    Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The promise of conjugate vaccines for Africa.
    Kieny MP; LaForce FM
    Vaccine; 2007 Sep; 25 Suppl 1():A108-10. PubMed ID: 17548136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.
    Poolman J; Borrow R
    Expert Rev Vaccines; 2011 Mar; 10(3):307-22. PubMed ID: 21434799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mucosal vaccination against encapsulated respiratory bacteria--new potentials for conjugate vaccines?
    Jakobsen H; Jonsdottir I
    Scand J Immunol; 2003 Aug; 58(2):119-28. PubMed ID: 12869132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease.
    Siber GR; Thompson C; Reid GR; Almeido-Hill J; Zacher B; Wolff M; Santosham M
    J Infect Dis; 1992 Jun; 165 Suppl 1():S129-33. PubMed ID: 1588146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
    Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Advances in vaccines and invasive disease in children].
    Moraga Llop FA
    Rev Esp Quimioter; 2001 Dec; 14(4):319-30. PubMed ID: 11856977
    [No Abstract]   [Full Text] [Related]  

  • 57. Conjugated polysaccharide vaccines.
    Ahmad H; Chapnick EK
    Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Conjugate vaccines].
    Swennen B; Sternon J
    Rev Med Brux; 2002 Sep; 23(4):A237-46. PubMed ID: 12422440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines.
    Käyhty H
    Biologicals; 1994 Dec; 22(4):397-402. PubMed ID: 7779368
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunization of newborns with bacterial conjugate vaccines.
    van den Biggelaar AH; Pomat WS
    Vaccine; 2013 May; 31(21):2525-30. PubMed ID: 22728221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.